Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/28/2025

Treatment of PTSD and Emotional Dysregulation in Patients with Intellectual Disability

Medication Management

  • The American Academy of Child and Adolescent Psychiatry recommends starting with a low dose (25-50mg daily) of sertraline and titrating slowly, as patients with intellectual disability may be more sensitive to medication side effects 1

Psychotherapeutic Interventions

  • Trauma-focused psychotherapy should be combined with sertraline for optimal treatment of PTSD symptoms, according to the American Academy of Child and Adolescent Psychiatry 2
  • Cognitive Behavioral Therapy (CBT) and Eye Movement Desensitization and Reprocessing (EMDR) are evidence-based treatments for PTSD, as recommended by the American Academy of Child and Adolescent Psychiatry and the International Society for the Study of Trauma and Dissociation 2, 3
  • The American Academy of Child and Adolescent Psychiatry suggests that patients with intellectual disability and complex trauma can benefit from trauma-focused treatments without requiring extensive stabilization phases first 3, 4

Special Considerations for Intellectual Disability

  • The American Academy of Child and Adolescent Psychiatry recommends that psychotropic medications should be part of a comprehensive treatment plan and not used as a substitute for appropriate support services 5
  • The American Academy of Child and Adolescent Psychiatry suggests using standardized symptom rating scales adapted for individuals with intellectual disability to monitor treatment response 6
  • Clear communication about medication effects and side effects should be ensured using language appropriate to the patient's cognitive level, as recommended by the American Academy of Child and Adolescent Psychiatry 1

Addressing Specific Symptoms

  • Sertraline is effective for anxiety symptoms that often co-occur with PTSD, according to the American College of Physicians 7

Monitoring and Follow-up

  • If inadequate response after 8-12 weeks of optimized sertraline treatment, consider augmentation with another agent, as suggested by the American Academy of Child and Adolescent Psychiatry 1
  • Switching to another SSRI or SNRI may be considered if inadequate response after 8-12 weeks of optimized sertraline treatment, according to the American Academy of Child and Adolescent Psychiatry 6
  • Referral to a psychiatrist specializing in intellectual disability may be considered if available, as recommended by the American Academy of Child and Adolescent Psychiatry 5